BioSpace News Archive

Business

Engrail Therapeutics and The Texas A&M University System Enter Licensing Agreement for Elesclomol in Disorders of Mitochondrial Copper Metabolism

Engrail Therapeutics™ (Engrail) (the Company), and The Texas A&M University System (TAMUS), today announced that they have entered into a license agreement which grants Engrail worldwide exclusive rights to intellectual property around the use of elesclomol for disorders of mitochondrial copper metabolism.

September 8, 2021
·
4 min read
Genetown

Xenetic Biosciences, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Xenetic Biosciences, Inc. today announced that Jeffrey F. Eisenberg, Chief Executive Officer of Xenetic will present at the virtual H.C. Wainwright 23rd Annual Global Investment Conference taking place September 13-15, 2021.

September 8, 2021
·
2 min read
Biotech Bay

Biotricity to Discuss Sales Expansion, Recent Financing, and Wearable Medical Device Portfolio Expansion at H.C. Wainwright Conference

Biotricity, Inc. today reported its CEO Waqaas Al-Siddiq is scheduled to present at the H.C. Wainwright 23rd Annual Global Investment Conference, which will be available on-demand starting at 7:00 a.m. ET on Monday, September 13, 2021.

September 8, 2021
·
2 min read
Business

IQVIA Collaborates with HealthCore to Advance Clinical Research Using Real-World Data

IQVIA™ (NYSE: IQV) announces its strategic collaboration with HealthCore, Inc. to advance real world evidence (RWE) studies with increased quality and efficiency.

September 8, 2021
·
4 min read
Bio NC

9 Meters Biopharma, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

9 Meters Biopharma, Inc. today announced that the Company’s CEO, John Temperato is scheduled to present at the H.C. Wainwright 23rd Annual Global Investment Conference as well as participate in one-on-one meetings with investors.

September 8, 2021
·
4 min read
BioCapital

Gain Therapeutics, Inc. Announces Positive Topline Data in Patient-derived iPSC Study Evaluating STAR Compounds as a Treatment for Gaucher and Parkinson’s Disease

Gain Therapeutics, Inc., a biotechnology company focused on identifying and optimizing allosteric binding sites never before targeted in neurodegenerative diseases and lysosomal storage disorders, announced topline data from the Company’s study, conducted at the University of Maryland School of Medicine.

September 8, 2021
·
11 min read
MIMEDX Announces Effectiveness of Shelf Registration Statement

MiMedx Group, Inc. today announced the shelf registration statement on Form S-3 on file with the Securities and Exchange Commission (SEC) has become effective.

September 8, 2021
·
3 min read
Vivos Therapeutics to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference

Vivos management to present at 7:00 am EDT on September 13, 2021

September 8, 2021
·
4 min read
Deals

Cipher Pharmaceuticals Announces Renewal of Normal Course Issuer Bid

Cipher Pharmaceuticals Inc. announced today that it has filed, and the Toronto Stock Exchange has accepted, notice of Cipher’s intention to renew its normal course issuer bid for its common shares

September 8, 2021
·
8 min read
Business

Bio-Thera Solutions Announces Commercialization and License Agreement for BAT1706, a Proposed Biosimilar Referencing Avastin® (Bevacizumab)

Bio-Thera Solutions Announces Commercialization and License Agreement for BAT1706, a Proposed Biosimilar Referencing Avastin ® (Bevacizumab)

September 8, 2021
·
4 min read